Ovarex anti-idiotype induction vaccine: Phase II/III trial in patients with advanced ovarian cancer.

AltaRex Corp. (ASE:AEX), Edmonton, Alberta Product: Ovarex anti-idiotype induction vaccine Indication: Ovarian cancer Status: AEX filed an IND in Canada for a blinded, placebo-controlled Phase II/III...